APP and Alzheimer disease: In early preclinical and advanced stages of AD, most reports show a notable reduction in the level of Aβ1-42 in CSF and serum, with alternatively cleaved amyloid precursor protein (APP) fragments also reduced compared to age matched controls [36–38].